LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients
Biomedical Chromatography · 2026-08 · 40 (8)
DOI: 10.1002/bmc.70539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 02.07.2026. Verfasst von Duygu Eryavuz Onmaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bandirma Onyedi Eylul University Faculty of Medicine, Bandirma, Turkey. Hauptthemen laut MEDLINE: Pregabalin, Tandem Mass Spectrometry, Neuralgia, gamma-Aminobutyric Acid. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
This study aimed to develop and validate a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay for the simultaneous quantification of pregabalin (PGB) and gabapentin (GBP) and to explore real‐world pharmacokinetic variability. A bioanalytical LC–MS/MS method was validated using serum samples prepared by acetonitrile protein precipitation. Chromatographic separation was achieved on a C18 column with gradient elution and positive electrospray ionization. The validated method was applied to serum samples obtained from 65 patients, and associations between serum drug concentrations and clinical measures were evaluated. The assay demonstrated excellent linearity ( R ² > 0.998), acceptable precision and accuracy, recovery ranging from 96.9% to 101.5%, and matrix effects below 7%. Considerable inter‐individual variability in serum concentrations was observed (PGB: median 700 ng/mL [IQR: 500–1000]; GBP: median 4500 ng/mL [IQR: 3200–5700]). No significant dose–concentration relationships were identified (PGB: ρ = 0.03; GBP: ρ = −0.08), and no significant associations were observed between serum concentrations and the clinical outcome measures assessed. In contrast, both drugs showed moderate inverse correlations with post‐dose sampling interval (PGB: ρ = −0.46; GBP: ρ = −0.45). These findings indicate substantial pharmacokinetic variability of gabapentinoids under routine clinical conditions. Although no clear dose–concentration or exposure–response relationships were identified in this cohort, interpretation should be made cautiously because of non‐standardized sampling conditions and the relatively narrow range of renal function among participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Bandirma Onyedi Eylul University Faculty of Medicine, Bandirma, Turkey.
- Department of Neurology, Selcuk University Faculty of Medicine, Konya, Turkey.
- Department of Biochemistry, Selcuk University Faculty of Medicine, Konya, Turkey.
ORCID-Profile: Duygu Eryavuz Onmaz, Fettah Eren
Zitieren
APA
Eryavuz Onmaz, D., Eren, F., Gulsen, K., Sak, F., Bik, M. A., Coban, R., Abusoglu, S., & Unlu, A. (2026). LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70539
Vancouver
Eryavuz Onmaz D, Eren F, Gulsen K, Sak F, Bik MA, Coban R, et al. LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70539
BibTeX
@article{EryavuzOnmaz2026,
author = {Eryavuz Onmaz, Duygu and Eren, Fettah and Gulsen, Kadir and Sak, Firdevs and Bik, Mohammad Ahmad and Coban, Rabia and Abusoglu, Sedat and Unlu, Ali},
title = {LC–MS/MS‐Based Monitoring of Pregabalin and Gabapentin Reveals Marked Pharmacokinetic Variability and Limited Exposure–Response Relationships in Neuropathic Pain Patients},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/bmc.70539}
}
EUVIMED